ACE2 News and Research

RSS
Genetic variation not linked with differences in COVID-19 morbidity and mortality

Genetic variation not linked with differences in COVID-19 morbidity and mortality

AI used to define the cytokine storm implicated in fatal COVID-19

AI used to define the cytokine storm implicated in fatal COVID-19

Researchers uncover an active role of glycans in SARS-CoV-2 spike protein

Researchers uncover an active role of glycans in SARS-CoV-2 spike protein

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

NeutrobodyPlex nanobodies help monitor SARS-CoV-2 immune responses

Bat and pangolin coronavirus structure sheds light on SARS-CoV-2 evolution

Bat and pangolin coronavirus structure sheds light on SARS-CoV-2 evolution

Bioinformatics analysis reveals genes and pathways shared in COVID-19 disease and comorbidities

Bioinformatics analysis reveals genes and pathways shared in COVID-19 disease and comorbidities

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

Molecular dynamic simulations reveal detailed spike-ACE2 interactions

Molecular dynamic simulations reveal detailed spike-ACE2 interactions

Common genetic variants may influence susceptibility to COVID-19

Common genetic variants may influence susceptibility to COVID-19

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

Nanoparticle SARS-CoV-2 model could potentially speed the search for drugs

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells

COVAM assay may help select convalescent plasma units for treatment of  acute COVID-19

COVAM assay may help select convalescent plasma units for treatment of acute COVID-19

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

SARS-CoV-2 infects monocytes and macrophages, without cytopathic effect

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

New method isolates antibody-like proteins that capture and neutralize SARS-CoV-2

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Adaptations found in RNA secondary structure in genes of two proteins of SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Genetic variants of human ACE2 are differentially recognized by SARS-CoV-2

Researchers develop non-infectious nanoparticle probes to study SARS-CoV-2

Researchers develop non-infectious nanoparticle probes to study SARS-CoV-2

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Key China COVID-19 study produced results that influenced subsequent research on coronavirus

Key China COVID-19 study produced results that influenced subsequent research on coronavirus